Why the study?
High blood pressure is a prevalent cause of chronic disease, and acute renal failure is an independent risk factor for morbidity, making survival analysis until acute renal failure and identifying associated factors of utmost significance.
In patients with high blood pressure, baseline kidney function, albuminuria, and gender are key predictors of progression to acute renal failure.
Baseline renal markers and gender may aid ARF risk stratification in hypertension; leaves open whether targeting them improves outcomes in trials.
Background: High blood pressure (HBP) is one of the most prevalent diseases which has affected many people in different societies. It is also the cause of several other chronic and fatal diseases. Acute renal failure (ARF) represents an independent risk factor for morbidity, resulting in a prolonged period of hospitalization of the survived patients. Thus, survival analysis of the patients with HBP until ARF and determination of the associated factors are of utmost significance. Materials and Methods: The current research examined the survival of patients with HBP until ARF using the Weibull model. We obtained the data from Systolic Blood Pressure Intervention Trial (SPRINT). The studied population included patients with systolic blood pressure (SBP of 130-180 mm Hg). The follow-up median was 3.26 years in our study. Results: Out of a total of 842 patients, 590 subjects (70.1%) were male and 252 subjects (29.9%) were female. Moreover, from these 842 patients, 85 (4.5%) died of cardiovascular diseases, 298 (15.7%) were diagnosed with ARF, and 459 (54.5%) were censored. According to the outcomes of the Weibull model of competing risks, the indexes of gender, albumin/creatinine ratio in urine, glomerular filtration rate, and being in the category of patients with chronic kidney disease (CKD) were effective factors associated with the survival of patients. Conclusion: According to the outcomes of this study, controlling blood pressure can greatly reduce the incidence of kidney failure.
No takes yet. Share an insight, caveat, or question.
Hashemian et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: